Tag Archives: NIDA

Organization in Ohio Is the New Holder of a DEA Marijuana Research License

Organization in Ohio Is the New Holder of a DEA Marijuana Research License

Organization in Ohio Is the New Holder of a DEA Marijuana Research License

While the United States Drug Enforcement Agency’s marijuana research license isn’t awarded lightly, an Ohio-based organization was recently awarded a Schedule I Researcher license by the DEA to study the effects of marijuana.


Battelle Receives DEA Approval for Marijuana Research

COLUMBUS, Ohio, Oct. 31, 2017 /Weed Wire/ — Battelle announced today that it was awarded a Schedule I Researcher license by the U.S. Drug Enforcement Administration (DEA), paving the way for the leading research and development organization to conduct marijuana research with human subjects.


Statement on the Adequacy of Marijuana Provided by NIDA for Phase 2 Clinical Trials for PTSD in Veterans

PHOENIX, March 17, 2017 /Weed Wire/ — As of March 15, 2017, five participants have received marijuana (cannabis) provided by the National Institute on Drug Abuse (NIDA) in an ongoing Phase 2 clinical trial sponsored by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) at the Scottsdale Research Institute (SRI) in Phoenix, Ariz. MAPS is committed to sponsoring rigorous clinical research to develop cannabis into a prescription medicine through the Food and Drug Administration (FDA).

Consumption Ban

Federal Survey Debunks Marijuana-Kids Myth (Again)

WASHINGTON, Dec. 13, 2016 /Weed Wire/ — The results of an annual survey of U.S. middle and high school students released Tuesday invalidate claims that reforming marijuana laws and debating legalization will lead to increased marijuana use among teens.

Americans for Safe Access Opioid Veterans Senate Committee

State Department States NIDA Monopoly on Research Marijuana Unnecessary

WASHINGTON, May 6, 2016 /Weed Wire/ — The Bureau of International Narcotics and Law Enforcement at the State Department has gone on record stating that the United States could issue multiple licenses for the cultivation of cannabis for medical and scientific purposes without violating the United Nations Single Convention on Narcotic Drugs treaty.


Is the Marijuana Industry Recession-Proof?

Some in the marijuana industry, based on their experiences on the job in the period between 2009 and 2013, believe that this industry vertical is actually anti-recessionary, even if it is not entirely shielded by “market correcting” events.


Marijuana Study for Veterans Faces Even More Delays

A highly anticipated study slated to test the efficacy of marijuana on veterans with post-traumatic stress disorder is still in limbo, despite a recent announcement that the National Institute of Drug Administration is ready to supply the researchers with the marijuana that they need.


Give Us the Research — We Can Handle It

Many were puzzled earlier this spring when Gov. Andrew Cuomo and the New York State legislature reached a deal to legalize medical marijuana, but only in vaporizable form and only for a list of conditions that changed up until the last moment.

PTSD plans

PTSD Pot Study Seeks New Home in AZ

As was expected by the appealing parties, Dr. Susan Sisley’s appeal for reinstatement to the University of Arizona faculty was denied. The decision is final, and subject to no further review according to a letter dated July 28, 2014, from Dr. Andrew Comrie, the Senior Vice President for Academic Affairs and Provost for the University of Arizona.